Hikma Pharmaceuticals PLC
HIK
Classement en actions
#25460
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Prix de l'action
$22.61
Capitalisation boursière
$46.82M
Changement (1 jour)
0.48%
Changement (1 an)
-52.37%
Pays
GB
Échange Hikma Pharmaceuticals PLC (HIK)
Catégorie
Healthcare
Capitalisation boursière de Hikma Pharmaceuticals PLC(HIK)
Capitalisation boursière: $46.82M
En October 2026, Hikma Pharmaceuticals PLC a une capitalisation boursière de $46.82M. Cela fait de Hikma Pharmaceuticals PLC la 25460th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Hikma Pharmaceuticals PLC du 2011 au 2026
HIK par rapport au top 5 des plus populaires stocks
